• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格雷夫斯病小鼠模型中促甲状腺素受体的刺激和阻断抗体的动力学

Dynamics of thyroid-stimulating and -blocking antibodies to the thyrotropin receptor in a murine model of Graves' disease.

作者信息

Muehlberg Tina, Gilbert Jacqueline A, Rao Prakash V, McGregor Alan M, Banga J Paul

机构信息

Guy's, King's and St Thomas' School of Medicine, Division of Medicine, London SE5 9PJ, United Kingdom.

出版信息

Endocrinology. 2004 Apr;145(4):1539-45. doi: 10.1210/en.2003-1456. Epub 2004 Feb 5.

DOI:10.1210/en.2003-1456
PMID:14764633
Abstract

Graves' disease is characterized by the presence of autoantibodies to the TSH receptor (TSHR). There are multiple antibodies to the TSHR, with thyroid-stimulating antibodies (TSAbs) and TSH-stimulating blocking antibodies (TSBAbs), which in patients can fluctuate over time, resulting in changes in disease activity. Recently, animal models of Graves' disease have been developed, but it is not known whether the induced TSAbs and TSBAbs change spontaneously with time to influence disease. We used fibroblasts expressing major histocompatability complex (MHC) class II and human TSHR murine model to study anti-TSHR antibody patterns in serial bleeds of 23 animals. Anti-TSHR antibody responses were first detectable after 7-8 wk of first immunization. Moreover, the pattern of the TSAbs or TSBAbs was selected early in the response. The majority of the animals showed anti-TSHR antibodies that were either TSAb or TSBAb responses and were maintained throughout the course of 17-24 wk of the experiment. Remarkably, a proportion of mice (13%) displayed presence of antibodies with both TSAbs and TSBAbs, which appeared to cycle over time and thus mimic the fluctuations described in some hyperthyroid patients. Analyses of the linear epitopes to TSHR by peptide scanning showed that there was no early restricted epitope response. Thus, despite using an inbred strain, the initial response appears to target different regions of the receptor in different animals. Our data show that anti-TSHR antibody epitopes in the model display heterogeneity in TSHR epitopes, which vary in individual animals as well as in their regulation.

摘要

格雷夫斯病的特征是存在针对促甲状腺激素受体(TSHR)的自身抗体。针对TSHR有多种抗体,包括甲状腺刺激抗体(TSAbs)和促甲状腺激素刺激阻断抗体(TSBAbs),在患者体内,这些抗体水平会随时间波动,导致疾病活动度发生变化。最近,已建立了格雷夫斯病的动物模型,但尚不清楚诱导产生的TSAbs和TSBAbs是否会随时间自发变化从而影响疾病。我们使用表达主要组织相容性复合体(MHC)II类分子和人TSHR的成纤维细胞小鼠模型,研究了23只动物连续采血中的抗TSHR抗体模式。首次免疫7 - 8周后首次检测到抗TSHR抗体反应。此外,TSAbs或TSBAbs的模式在反应早期就已确定。大多数动物显示出的抗TSHR抗体要么是TSAb反应,要么是TSBAb反应,并且在整个17 - 24周的实验过程中保持稳定。值得注意的是,一部分小鼠(13%)同时出现了TSAbs和TSBAbs两种抗体,它们似乎随时间循环变化,从而模拟了一些甲状腺功能亢进患者中描述的波动情况。通过肽扫描对TSHR线性表位进行分析表明,早期没有受限的表位反应。因此,尽管使用的是近交系,不同动物的初始反应似乎针对受体的不同区域。我们的数据表明,该模型中的抗TSHR抗体表位在TSHR表位方面表现出异质性,在个体动物及其调节方面都有所不同。

相似文献

1
Dynamics of thyroid-stimulating and -blocking antibodies to the thyrotropin receptor in a murine model of Graves' disease.格雷夫斯病小鼠模型中促甲状腺素受体的刺激和阻断抗体的动力学
Endocrinology. 2004 Apr;145(4):1539-45. doi: 10.1210/en.2003-1456. Epub 2004 Feb 5.
2
Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.在特发性黏液性水肿中鉴定促甲状腺素受体上与格雷夫斯病促甲状腺素刺激抗体和促甲状腺素阻断抗体反应的不同决定簇:这些决定簇在促性腺激素受体上没有同源序列。
Mol Endocrinol. 1992 Feb;6(2):168-80. doi: 10.1210/mend.6.2.1349156.
3
Insight into Graves' hyperthyroidism from animal models.从动物模型看格雷夫斯病甲亢
Endocr Rev. 2005 Oct;26(6):800-32. doi: 10.1210/er.2004-0023. Epub 2005 Apr 12.
4
Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy.放射性碘治疗后短暂性甲状腺功能减退期间出现的促甲状腺素阻断抗体的特征分析。
Thyroid. 2000 Oct;10(10):909-17. doi: 10.1089/thy.2000.10.909.
5
Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.对源自格雷夫斯病患者淋巴细胞的重组单克隆抗促甲状腺素受体抗体(TSHRAbs)的特性分析:两种刺激性TSHRAbs的表位及结合研究
Endocrinology. 1999 Apr;140(4):1594-601. doi: 10.1210/endo.140.4.6664.
6
Low-dose immunization with adenovirus expressing the thyroid-stimulating hormone receptor A-subunit deviates the antibody response toward that of autoantibodies in human Graves' disease.用表达促甲状腺激素受体A亚基的腺病毒进行低剂量免疫,可使人Graves病的抗体反应偏向自身抗体的反应。
Endocrinology. 2004 Jan;145(1):228-33. doi: 10.1210/en.2003-1134. Epub 2003 Oct 23.
7
Contrasting activities of thyrotropin receptor antibodies in experimental models of Graves' disease induced by injection of transfected fibroblasts or deoxyribonucleic acid vaccination.注射转染成纤维细胞或脱氧核糖核酸疫苗诱导的格雷夫斯病实验模型中促甲状腺激素受体抗体的对比活性
Endocrinology. 2003 Jan;144(1):260-6. doi: 10.1210/en.2002-220688.
8
Regulation and transfer of a murine model of thyrotropin receptor antibody mediated Graves' disease.促甲状腺素受体抗体介导的格雷夫斯病小鼠模型的调控与转移
Endocrinology. 1999 Mar;140(3):1392-8. doi: 10.1210/endo.140.3.6599.
9
Hashimoto's thyroiditis with heterogeneous antithyrotropin receptor antibodies: unique epitopes may contribute to the regulation of thyroid function by the antibodies.伴有异质性促甲状腺激素受体抗体的桥本甲状腺炎:独特表位可能有助于抗体对甲状腺功能的调节。
J Clin Endocrinol Metab. 2000 Jun;85(6):2116-21. doi: 10.1210/jcem.85.6.6639.
10
The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.在格雷夫斯病动物模型中,促甲状腺激素受体(TSHR)抗体的形成需要TSHR细胞外结构域的N端片段。
Endocrinology. 1998 Apr;139(4):1891-8. doi: 10.1210/endo.139.4.5876.

引用本文的文献

1
Spatial distribution and determinants of thyroid cancer incidence from 1999 to 2013 in Korea.韩国 1999 年至 2013 年甲状腺癌发病率的空间分布及决定因素。
Sci Rep. 2021 Nov 18;11(1):22474. doi: 10.1038/s41598-021-00429-w.
2
PRL-1 overexpressed placenta-derived mesenchymal stem cells suppress adipogenesis in Graves' ophthalmopathy through SREBP2/HMGCR pathway.过表达 PRL-1 的胎盘间充质干细胞通过 SREBP2/HMGCR 通路抑制格雷夫斯眼病的脂肪生成。
Stem Cell Res Ther. 2021 May 29;12(1):304. doi: 10.1186/s13287-021-02337-2.
3
Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves Disease.
格雷夫斯病中功能性促甲状腺素受体抗体的前瞻性试验
J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1006-14. doi: 10.1210/clinem/dgz292.
4
Graves' Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies.格雷夫斯病的发病机制:刺激性、阻断性和裂解区促甲状腺激素受体抗体的作用
Horm Metab Res. 2015 Sep;47(10):727-34. doi: 10.1055/s-0035-1559633. Epub 2015 Sep 11.
5
Immunoglobulin heavy chain variable region genes contribute to the induction of thyroid-stimulating antibodies in recombinant inbred mice.免疫球蛋白重链可变区基因有助于诱导重组近交系小鼠产生促甲状腺素抗体。
Genes Immun. 2010 Apr;11(3):254-63. doi: 10.1038/gene.2010.8.
6
Thyroid antigens, not central tolerance, control responses to immunization in BALB/c versus C57BL/6 mice.甲状腺抗原而非中枢耐受,控制BALB/c小鼠与C57BL/6小鼠对免疫的反应。
Thyroid. 2009 May;19(5):503-9. doi: 10.1089/thy.2008.0420.